Home Cart 0 Sign in  

[ CAS No. 21919-05-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 21919-05-1
Chemical Structure| 21919-05-1
Structure of 21919-05-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 21919-05-1 ]

Related Doc. of [ 21919-05-1 ]

Alternatived Products of [ 21919-05-1 ]

Product Details of [ 21919-05-1 ]

CAS No. :21919-05-1 MDL No. :
Formula : C9H8N4O5 Boiling Point : -
Linear Structure Formula :- InChI Key :WOCXQMCIOTUMJV-UHFFFAOYSA-N
M.W : 252.18 Pubchem ID :89105
Synonyms :
Chemical Name :5-(Aziridin-1-yl)-2,4-dinitrobenzamide

Calculated chemistry of [ 21919-05-1 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 4
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 67.21
TPSA : 137.74 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.85 cm/s

Lipophilicity

Log Po/w (iLOGP) : -0.03
Log Po/w (XLOGP3) : -0.02
Log Po/w (WLOGP) : 0.04
Log Po/w (MLOGP) : -1.08
Log Po/w (SILICOS-IT) : -3.35
Consensus Log Po/w : -0.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.37
Solubility : 10.7 mg/ml ; 0.0423 mol/l
Class : Very soluble
Log S (Ali) : -2.42
Solubility : 0.952 mg/ml ; 0.00378 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.64
Solubility : 57.6 mg/ml ; 0.229 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.57

Safety of [ 21919-05-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 21919-05-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 21919-05-1 ]

[ 21919-05-1 ] Synthesis Path-Downstream   1~6

  • 1
  • [ 21919-05-1 ]
  • 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With phosphate buffer; sodium formate Irradiation;
With 1,4-dihydronicotinamide adenine dinucleotide; rat quinone reductase In phosphate buffer at 37℃;
Multi-step reaction with 2 steps 1: NQO2 enzyme 2: NQO2 enzyme
  • 2
  • [ 21919-05-1 ]
  • 5-(aziridin-1-yl)-2-nitro-4-nitrosobenzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With NQO2 enzyme
  • 3
  • [ 21919-05-1 ]
  • 5-(aziridin-1-yl)-2-hydroxylamino-4-nitrobenzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With 1,4-dihydronicotinamide adenine dinucleotide; Escherichia coli K12 nitroreductase In dimethyl sulfoxide at 25℃; for 0.0833333h;
  • 4
  • [ 21919-05-1 ]
  • 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide [ No CAS ]
  • 5-(aziridin-1-yl)-2-hydroxylamino-4-nitrobenzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
Stage #1: tretazicar With potassium carbonate In methanol at 60℃; Stage #2: With dihydroxyacetone In methanol at 60℃; for 0.25h; 9 A solution of 5-(aziridin-l-yl)-254-dinitrobenzamide ("CB 1954", 1.00 g, 3.97 mmol) in methanol ('AnalaR'-grade, 40 mL) was treated with excess powdered anhydrous K2CO3 (10.0 g, 72 mmol; aprox. 18 equiv.) and the mixture was heated to 6O0C with stirring. The suspension was stirred at 600C beneath a N2 blanket stream atmosphere. A solution of 1,3-dihydroxyacetone (1.50 g as DHA dimer, 8.33 mmol; 2.1 mol equiv) in methanol ('AαalaR'-grade, 40 mL), previously deaerated by flushing with N2 gas, was then added during 15 min to the reaction mixture with rapid stirring while maintaining the temperature at 60°C. A fast reaction is observed with a colour change from pale yellow-orange to brown. Thin-layer chromatography (TLC; Merck silica gel 60 GF254 on aluminium sheets, 9:1 v/v CH2Cl2 : MeOH) showed quantitative removal of the CB 1954 starting material (Rf 0.73) and formation of two polar products at Rf 0.53 and Rf 0.47. The two products showed identical TLC behaviour to authentic 5-(aziridin- 1 -yl)-2-hydroxylarnmo-4-nitrobenzamide and 5-(aziridin- 1 -yl)-4-hydroxylamino- 2-nitrobenzamide samples, respectively, prepared by published methods [Knox, RJ., Friedlos, F., Jarman, M., Roberts, JJ. Biochemical Pharmacology 37, 4661- 4669 (1988); Knox, RJ., Friedlos, F., Biggs, PJ., Flitter, W.D. Gaskell, M., Goddard, P., Davies, L., Jarman, M. Biochemical Pharmacology 46, 797-803 (1993)].The reaction mixture was filtered while hot and the insoluble material was washed with cold methanol (10 mL). The combined filtrate was cooled and rotary evaporated (3O0C, high-vacuum) to give a viscous yellow-brown oil (1.02 g, >100%). TLC examination confirmed that two major products were present. Minor spots (2 gas to prevent oxidation of the hydroxylamines to nitroso products and unwanted coloured by-products). The 2- hydroxylamine (Rf 0.53) and 4-hydroxylamine (Rf 0.47) reaction products were judged to be formed in ~40:60 ratio. Chromatographic separation of the isomers is hampered by their close elution properties using available solvent systems. However, flash chromatographic separation of a crude mixture sample (100 mg) (Merck silica gel, 60-200 mesh, 9:1 v/v CH2Cl2-MeOH) gave 5-(aziridin-l-yl)-2- hydroxylamino-4-nitrobenzamide (31 mg) and 5-(aziridin-l-yl)-4-hydroxylamino- 2-nitrobenzamide (49 mg) after solvent removal from fractions. Both products gave NMR spectra consistent with the reported properties for the isomeric hydroxylamines and TLC behaviour that was indistinguishable with the authentic compounds [Knox, RJ., Friedlos, F., Jarman, M., Roberts, JJ. Biochemical Pharmacology 37, 4661-4669 (1988)].Notes: (1) The preferred reaction solvent is methanol. 1,3-Dihydroxyacetone (DHA) dimer has limited solubility in many common solvents, including acetone and higher alcohols.(2) Reaction is almost instantaneous at 600C but is slower at lower temperatures. The use of higher temperature reaction systems may have an adverse effect on relative product yield.The product hydroxylamines show greater sensitivity to air oxidation in the presence of alkali, hence it is recommended that the K2CO3 reagent is removed from the reaction mixture as soon as possible. Chromatographic separation of the mixture containing the 2- and 4-hydroxylamine products requires minimisation of any exposure for dissolved material to O2 (air) during handling.
  • 5
  • [ 21919-05-1 ]
  • 4-amino metabolite [ No CAS ]
  • [ 61837-26-1 ]
  • 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide [ No CAS ]
  • 5-(aziridin-1-yl)-2-hydroxylamino-4-nitrobenzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With His6-tagged Staphylococcus saprophyticus DSM 20229/ATCC 15305 nitroreductase; <i>O</i>5'-phosphono-riboflavin; NADPH In dimethyl sulfoxide at 15℃; aq. phosphate buffer; Enzymatic reaction; 2.10. Enzyme assays with electron acceptors General procedure: Cofactor preference (NADPH or NADH) of Ssap-NtrB catalysed reactions was carried out using K3[Fe(CN)6], as an artificial electron acceptor. In a typical reaction, 1 mM (saturating concentration) of K3[Fe(CN)6] in 50 mM Tris-Cl buffer pH 7.0 was incubated with 50 μg/ml of Ssap-NtrB for 3 min at 15 °C and the reaction was initiated by addition of either NADPH or NADH at varying concentrations. The reaction was monitored spectrophotometrically at 340 nm for 10 min. Steady state enzyme kinetics with purified Ssap-NtrB as a prodrug activator enzyme was monitored using both CB1954 and SN23862. In a typical reaction, series of CB1954 in the range of 0.05-4 mM or SN23862 (0-165 μM) was prepared in 50 mM Tris-Cl (pH 7.0) buffer containing 4% DMSO. To this solution, Ssap-NtrB was added to give final concentrations of 12.5 μg/ml. The reaction was then started by addition of NADPH at final concentration of 200 μM and monitored at 420 nm (based on equal absorption of both 2- and 4-hydroxylamine reduction product of CB1954 at this wavelength; ε420 = 1200 M-1 cm-1)43 for CB1954 and 340 nm (based on NADPH usage; ε340 = 6220 M-1 cm-1)44 for SN23862.All kinetics measurements were performed using Uv-vis spectrophotometer (Shimadzu UV-3600) equipped with a circulating water bath (VWR model 1162A). Nonlinear regression analysis and Michaelis-Menten curve fitting was performed using Origin v.7 software (OriginLab, Northampton, MA). One unit (U) is defined as the amount of the enzyme that catalyses the conversion of 1 μmol of substrate per minute under the experimental conditions specified. The specific activity was expressed as μmol min-1 mg-1active enzyme.
With NADPH In aq. phosphate buffer at 37℃; for 0.5h; Enzymatic reaction; 2.5. Enzyme reactivity with CB1954 The ability of the purified proteins to reduce the CB1954 prodrugwas confirmed following the method previously described by Gweninet al. (2011a). Briefly, the proteins were incubated with NADH(300 μM) and CB1954 (100 μM) in phosphate buffer (PB) (50 mM,pH 7.2) and scanned using UV-visible spectroscopy every 90 s for15 min. For active NTR/CB1954 combinations, product formation wasmeasured at 420 nm (Gwenin et al., 2015, 2011a).
YieldReaction ConditionsOperation in experiment
With Thermotoga maritima peroxiredoxin–nitroreductase hybrid enzyme; NADH In aq. buffer at 25℃;
Same Skeleton Products
Historical Records